Jazz Pharmaceuticals plc Long-Lived Assets
Jazz Pharmaceuticals plc (JAZZ) had Long-Lived Assets of $14.25 million as of 2013-12-31, per its 10-K filed 2014-02-25.
Discontinued › Notes
us-gaap:NoncurrentAssets · last filed 2014-02-25
- 2013-12-31: Long-Lived Assets $14.25M.
- 2013-09-30: Long-Lived Assets $12.06M.
- 2013-06-30: Long-Lived Assets $10.77M.
- 2013-03-31: Long-Lived Assets $7.79M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2013-12-31 | $14.25M 10-K · filed 2014-02-25 | |
| 2013-09-30 | $12.06M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $10.77M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $7.79M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $7.28M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $1.34B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.40B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $568.22M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $1.56M 10-K · filed 2013-02-26 | $54.44M 10-Q · filed 2012-08-07 |
| 2011-03-31 | $54.44M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |